2023

1. C-Type Lectin Receptor Mediated Modulation of T2 Immune Responses to Allergens

   Current Allergy and Asthma Reports, Vol. 23, Núm. 3, pp. 141-151

2. Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation

   Frontiers in Immunology, Vol. 14

3. Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation

   Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 4, pp. 1060-1072